Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Plasma EBV-load as an early biomarker and prognostic factor of HIV-related lymphomas.

Muncunill J, Baptista MJ, Hernandez-Rodríguez Á, Dalmau J, Garcia O, Tapia G, Moreno M, Sancho JM, Martínez-Picado J, Feliu E, Mate JL, Ribera JM, Navarro JT.

Clin Infect Dis. 2018 Jun 29. doi: 10.1093/cid/ciy542. [Epub ahead of print]

PMID:
29982484
2.

Pharmacological modulation of CXCR4 cooperates with BET bromodomain inhibition in diffuse large B-cell lymphoma.

Recasens-Zorzo C, Cardesa-Salzmann T, Petazzi P, Ros-Blanco L, Esteve-Arenys A, Clot G, Guerrero-Hernández M, Rodríguez V, Soldini D, Valera A, Moros A, Climent F, González-Barca E, Mercadal S, Arenillas L, Calvo X, Mate JL, Gutiérrez-García G, Casanova I, Mangues R, Sanjuan-Pla A, Bueno C, Menéndez P, Martínez A, Colomer D, Estrada-Tejedor R, Teixidó J, Campo E, López-Guillermo A, Borrell JI, Colomo L, Pérez-Galán P, Roué G.

Haematologica. 2018 Jun 28. pii: haematol.2017.180505. doi: 10.3324/haematol.2017.180505. [Epub ahead of print]

3.

Hydroxyurea-Induced Pneumopathy in a Patient With Myeloproliferative Syndrome.

Galván OP, Moltó HP, Fabià-Mayans A, Xicoy B, Mate JL, Martí PR.

Clin Med Insights Case Rep. 2018 Apr 23;11:1179547618770688. doi: 10.1177/1179547618770688. eCollection 2018.

4.

Kallikreins Stepwise Scoring Reveals Three Subtypes of Papillary Thyroid Cancer with Prognostic Implications.

Buj R, Mallona I, Díez-Villanueva A, Zafon C, Mate JL, Roca M, Puig-Domingo M, Reverter JL, Mauricio D, Peinado MA, Jordà M.

Thyroid. 2018 May;28(5):601-612. doi: 10.1089/thy.2017.0501.

PMID:
29635968
5.

MYC-rearranged lymphomas other than Burkitt: Comparison between R-CHOP and Burkitt-type immunochemotherapy.

Baptista MJ, Tapia G, Hernández-Rivas JÁ, Martínez-Trillos A, Mate JL, Navarro JT.

Med Clin (Barc). 2017 Oct 23;149(8):339-342. doi: 10.1016/j.medcli.2017.03.056. Epub 2017 Jun 23. English, Spanish.

PMID:
28648593
6.

HIV-infection has no prognostic impact on advanced-stage Hodgkin lymphoma.

Sorigué M, García O, Tapia G, Baptista MJ, Moreno M, Mate JL, Sancho JM, Feliu E, Ribera JM, Navarro JT.

AIDS. 2017 Jun 19;31(10):1445-1449. doi: 10.1097/QAD.0000000000001487.

PMID:
28574963
7.

LMO2-negative Expression Predicts the Presence of MYC Translocations in Aggressive B-Cell Lymphomas.

Colomo L, Vazquez I, Papaleo N, Espinet B, Ferrer A, Franco C, Comerma L, Hernandez S, Calvo X, Salar A, Climent F, Mate JL, Forcada P, Mozos A, Nonell L, Martinez A, Carrio A, Costa D, Dlouhy I, Salaverria I, Martin-Subero JI, Lopez-Guillermo A, Valera A, Campo E; Grup per l’Estudi dels Limfomes de Catalunya i Balears (GELCAB).

Am J Surg Pathol. 2017 Jul;41(7):877-886. doi: 10.1097/PAS.0000000000000839.

PMID:
28288039
8.

Similar prognosis of transformed and de novo diffuse large B-cell lymphomas in patients treated with immunochemotherapy.

Sorigue M, Garcia O, Baptista MJ, Sancho JM, Tapia G, Mate JL, Feliu E, Navarro JT, Ribera JM.

Med Clin (Barc). 2017 Mar 22;148(6):243-249. doi: 10.1016/j.medcli.2016.09.050. Epub 2016 Dec 27. English, Spanish.

PMID:
28038857
9.

Intravascular (blood vessel) histiocytosis with haemophagocytosis.

Fernández-Figueras MT, Martín-Urdà MT, Plana A, Servitje O, Penin RM, Tapia G, Mate JL, Ariza A.

Histopathology. 2016 Dec;69(6):1077-1081. doi: 10.1111/his.13030. Epub 2016 Sep 16.

PMID:
27380612
10.

Aberrant gene methylation and bronchial dysplasia in high risk lung cancer patients.

Rosell A, Rodríguez N, Monsó E, Taron M, Millares L, Ramírez JL, López-Lisbona R, Cubero N, Andreo F, Sanz J, Llatjós M, Llatjós R, Fernández-Figueras MT, Mate JL, Català I, Setó L, Roset M, Díez-Ferrer M, Dorca J.

Lung Cancer. 2016 Apr;94:102-7. doi: 10.1016/j.lungcan.2016.02.003. Epub 2016 Feb 11.

PMID:
26973214
11.

[Leukemic transformation of Langerhans cell sarcoma].

Botin T, Navarro JT, Juncà J, Mate JL.

Med Clin (Barc). 2016 May 6;146(9):418-9. doi: 10.1016/j.medcli.2015.11.039. Epub 2016 Jan 26. Spanish. No abstract available.

PMID:
26823107
12.

ROS1 copy number alterations are frequent in non-small cell lung cancer.

Clavé S, Gimeno J, Muñoz-Mármol AM, Vidal J, Reguart N, Carcereny E, Pijuan L, Menéndez S, Taus Á, Mate JL, Serrano S, Albanell J, Espinet B, Arriola E, Salido M.

Oncotarget. 2016 Feb 16;7(7):8019-28. doi: 10.18632/oncotarget.6921.

13.

MYC protein expression is associated with poor prognosis in primary diffuse large B-cell lymphoma of the central nervous system.

Tapia G, Baptista MJ, Muñoz-Marmol AM, Gaafar A, Puente-Pomposo M, Garcia O, Marginet-Flinch R, Sanz C, Navarro JT, Sancho JM, Ribera JM, Ariza A, Mate JL.

APMIS. 2015 Jul;123(7):596-603. doi: 10.1111/apm.12390. Epub 2015 May 22.

PMID:
26010683
14.

A depth refugium from catastrophic coral bleaching prevents regional extinction.

Smith TB, Glynn PW, Maté JL, Toth LT, Gyory J.

Ecology. 2014 Jun;95(6):1663-73.

PMID:
25039230
15.

A case of CD138-/CD19+/CD4+ IgD plasma cell leukemia.

Sorigue M, Juncà J, Gassiot S, Millá F, Mate JL, Navarro JT.

Cytometry B Clin Cytom. 2015 Jan;88(1):69-73. doi: 10.1002/cyto.b.21173. Epub 2014 Apr 9.

16.

A case of CD138-/CD19+/CD4+ IgD plasma cell leukemia.

Sorigue M, Juncà J, Gassiot S, Millá F, Mate JL, Navarro JT.

Cytometry B Clin Cytom. 2014 Mar 22. doi: 10.1002/cytob.21173. [Epub ahead of print]

17.

The truncated isoform of somatostatin receptor5 (sst5TMD4) is associated with poorly differentiated thyroid cancer.

Puig-Domingo M, Luque RM, Reverter JL, López-Sánchez LM, Gahete MD, Culler MD, Díaz-Soto G, Lomeña F, Squarcia M, Mate JL, Mora M, Fernández-Cruz L, Vidal O, Alastrué A, Balibrea J, Halperin I, Mauricio D, Castaño JP.

PLoS One. 2014 Jan 21;9(1):e85527. doi: 10.1371/journal.pone.0085527. eCollection 2014.

18.

MYC status determination in aggressive B-cell lymphoma: the impact of FISH probe selection.

Muñoz-Mármol AM, Sanz C, Tapia G, Marginet R, Ariza A, Mate JL.

Histopathology. 2013 Sep;63(3):418-24. doi: 10.1111/his.12178. Epub 2013 Jun 24.

PMID:
23795946
19.

MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.

Valera A, López-Guillermo A, Cardesa-Salzmann T, Climent F, González-Barca E, Mercadal S, Espinosa I, Novelli S, Briones J, Mate JL, Salamero O, Sancho JM, Arenillas L, Serrano S, Erill N, Martínez D, Castillo P, Rovira J, Martínez A, Campo E, Colomo L; Grup per l’Estudi dels Limfomes de Catalunya i Balears (GELCAB).

Haematologica. 2013 Oct;98(10):1554-62. doi: 10.3324/haematol.2013.086173. Epub 2013 May 28.

20.

Cutaneous presentation of chronic lymphocytic leukemia as unique extramedullar involvement in a patient with normal peripheral blood lymphocyte count (monoclonal B-cell lymphocytosis).

Tapia G, Mate JL, Fuente MJ, Navarro JT, Fernández-Figueras MT, Juncà J, Ferrándiz C, Ariza A.

J Cutan Pathol. 2013 Aug;40(8):740-4. doi: 10.1111/cup.12167. Epub 2013 May 3.

PMID:
23639136
21.

[Association over time of Hodgkin lymphoma and non-Hodgkin lymphoma: study of 6 patients in one single center].

Pérez-Montaña A, Sancho JM, Mate JL, Ribera JM.

Med Clin (Barc). 2012 Dec 15;139(15):695-6. doi: 10.1016/j.medcli.2012.05.014. Epub 2012 Jul 17. Spanish. No abstract available.

PMID:
22809967
22.

Fetal-maternal interface: a chronicle of allogeneic coexistence.

Pujal JM, Roura S, Muñoz-Marmol AM, Mate JL, Bayes-Genis A.

Chimerism. 2012 Jan-Mar;3(1):18-20.

23.

Cutaneous B-cell lymphoma: the importance of clinicopathologic correlation.

Morell L, Bassas-Vila J, Mate JL, Bielsa I.

Actas Dermosifiliogr. 2012 Oct;103(8):746-8. Epub 2012 May 9. English, Spanish. No abstract available.

PMID:
22579036
24.

Improved clonality detection in Hodgkin lymphoma using the BIOMED-2-based heavy and kappa chain assay: a paraffin-embedded tissue study.

Tapia G, Sanz C, Mate JL, Muñoz-Mármol AM, Ariza A.

Histopathology. 2012 Apr;60(5):768-73. doi: 10.1111/j.1365-2559.2011.04135.x. Epub 2012 Feb 1.

PMID:
22296097
25.

Immunohistochemical detection of MYC protein correlates with MYC gene status in aggressive B cell lymphomas.

Tapia G, Lopez R, Muñoz-Mármol AM, Mate JL, Sanz C, Marginet R, Navarro JT, Ribera JM, Ariza A.

Histopathology. 2011 Oct;59(4):672-8. doi: 10.1111/j.1365-2559.2011.03978.x.

PMID:
22014048
26.

Scoring systems in mantle cell lymphoma: a critical point of view.

Juncà J, Ruiz-Xivillé N, Granada I, Rodríguez-Hernández I, Navarro JT, Mate JL, Millá F.

Cytometry B Clin Cytom. 2012 Mar;82(2):120-2. doi: 10.1002/cyto.b.20620. Epub 2011 Sep 13.

27.

Discrepancy between clinical criteria for diagnosing acute respiratory distress syndrome secondary to community acquired pneumonia with autopsy findings of diffuse alveolar damage.

Sarmiento X, Guardiola JJ, Almirall J, Mesalles E, Mate JL, Soler M, Klamburg J.

Respir Med. 2011 Aug;105(8):1170-5. doi: 10.1016/j.rmed.2011.04.001. Epub 2011 May 12.

28.

High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy.

Cardesa-Salzmann TM, Colomo L, Gutierrez G, Chan WC, Weisenburger D, Climent F, González-Barca E, Mercadal S, Arenillas L, Serrano S, Tubbs R, Delabie J, Gascoyne RD, Connors JM, Mate JL, Rimsza L, Braziel R, Rosenwald A, Lenz G, Wright G, Jaffe ES, Staudt L, Jares P, López-Guillermo A, Campo E.

Haematologica. 2011 Jul;96(7):996-1001. doi: 10.3324/haematol.2010.037408. Epub 2011 May 5.

29.

Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.

Gutiérrez-García G, Cardesa-Salzmann T, Climent F, González-Barca E, Mercadal S, Mate JL, Sancho JM, Arenillas L, Serrano S, Escoda L, Martínez S, Valera A, Martínez A, Jares P, Pinyol M, García-Herrera A, Martínez-Trillos A, Giné E, Villamor N, Campo E, Colomo L, López-Guillermo A; Grup per l'Estudi dels Limfomes de Catalunya I Balears (GELCAB).

Blood. 2011 May 5;117(18):4836-43. doi: 10.1182/blood-2010-12-322362. Epub 2011 Mar 25.

30.

Pretreatment EGFR T790M mutation and BRCA1 mRNA expression in erlotinib-treated advanced non-small-cell lung cancer patients with EGFR mutations.

Rosell R, Molina MA, Costa C, Simonetti S, Gimenez-Capitan A, Bertran-Alamillo J, Mayo C, Moran T, Mendez P, Cardenal F, Isla D, Provencio M, Cobo M, Insa A, Garcia-Campelo R, Reguart N, Majem M, Viteri S, Carcereny E, Porta R, Massuti B, Queralt C, de Aguirre I, Sanchez JM, Sanchez-Ronco M, Mate JL, Ariza A, Benlloch S, Sanchez JJ, Bivona TG, Sawyers CL, Taron M.

Clin Cancer Res. 2011 Mar 1;17(5):1160-8. doi: 10.1158/1078-0432.CCR-10-2158. Epub 2011 Jan 13.

31.

[Study on the clinicopathological correlation in the secondary acute respiratory distress syndrome].

Sarmiento X, Almirall J, Guardiola JJ, Mesalles E, Labarta L, Mate JL, Soler M, Klamburg J.

Med Intensiva. 2011 Jan-Feb;35(1):22-7. doi: 10.1016/j.medin.2010.08.001. Epub 2010 Dec 22. Spanish.

32.

Translocation (3;8)(q27;q24) in two cases of triple hit lymphoma.

Motlló C, Grau J, Juncà J, Ruiz N, Mate JL, Orna E, Navarro JT, Vives S, Sancho JM, Esteban D, Granada I, Feliu E, Ribera JM, Millá F.

Cancer Genet Cytogenet. 2010 Dec;203(2):328-32. doi: 10.1016/j.cancergencyto.2010.08.018.

PMID:
21156254
33.

Immunohistochemical expression profile and prognosis in patients with diffuse large B-cell lymphoma with or without human immunodeficiency virus infection.

Xicoy B, Ribera JM, Mate JL, Tapia G, Morgades M, Navarro JT, Sanz C, Ariza A, Feliu E.

Leuk Lymphoma. 2010 Nov;51(11):2063-9. doi: 10.3109/10428194.2010.520772. Epub 2010 Oct 7.

PMID:
20929323
34.

Plasma Epstein-Barr viral load measurement as a diagnostic marker of lymphoma in HIV-infected patients.

Navarro JT, Hernández A, Rodríguez-Manzano J, Mate JL, Grau J, Morgades M, Martró E, Tural C, Ribera JM, Matas L.

Med Clin (Barc). 2010 Oct 9;135(11):485-90. doi: 10.1016/j.medcli.2010.02.041. Epub 2010 Jul 31.

PMID:
20673682
35.

[Concomitant diagnosis of acute myeloid leukaemia and chronic lymphoproliferative disorder with AA amyloidosis as a final event].

Juncà J, Moreno M, Mate JL, Milla F.

Med Clin (Barc). 2010 Jun 19;135(3):136-7. doi: 10.1016/j.medcli.2009.04.052. Epub 2009 Sep 18. Spanish. No abstract available.

PMID:
19766258
36.

Metabolic fingerprinting of fresh lymphoma samples used to discriminate between follicular and diffuse large B-cell lymphomas.

Barba I, Sanz C, Barbera A, Tapia G, Mate JL, Garcia-Dorado D, Ribera JM, Oriol A.

Exp Hematol. 2009 Nov;37(11):1259-65. doi: 10.1016/j.exphem.2009.08.006. Epub 2009 Aug 29.

PMID:
19720109
37.

Lymphogranuloma venerium proctitis in the setting of HIV: a case report and differential diagnosis.

Heras E, Llibre JM, Sirera G, Mate JL, Boix V, Rey-Joly C, Clotet B.

AIDS Patient Care STDS. 2009 Jul;23(7):493-4. doi: 10.1089/apc.2008.0261. No abstract available.

PMID:
19534601
38.

Activation of the endoplasmic reticulum stress-associated transcription factor x box-binding protein-1 occurs in a subset of normal germinal-center B cells and in aggressive B-cell lymphomas with prognostic implications.

Balague O, Mozos A, Martinez D, Hernandez L, Colomo L, Mate JL, Teruya-Feldstein J, Lin O, Campo E, Lopez-Guillermo A, Martinez A.

Am J Pathol. 2009 Jun;174(6):2337-46. doi: 10.2353/ajpath.2009.080848. Epub 2009 Apr 23.

39.

Regulatory T cells in type 1 diabetic patients with autoimmune chronic atrophic gastritis.

Alonso N, Martínez-Arconada MJ, Granada ML, Soldevila B, Cantón A, Mate JL, Sanmartí A, Martínez-Cáceres EM.

Endocrine. 2009 Jun;35(3):420-8. doi: 10.1007/s12020-009-9166-2. Epub 2009 Mar 17.

PMID:
19291424
40.

A sensitive method for detecting EGFR mutations in non-small cell lung cancer samples with few tumor cells.

Molina-Vila MA, Bertran-Alamillo J, Reguart N, Taron M, Castellà E, Llatjós M, Costa C, Mayo C, Pradas A, Queralt C, Botia M, Pérez-Cano M, Carrasco E, Tomàs M, Mate JL, Moran T, Rosell R.

J Thorac Oncol. 2008 Nov;3(11):1224-35. doi: 10.1097/JTO.0b013e318189f579.

41.

Decrease in the frequency of meningeal involvement in AIDS-related systemic lymphoma in patients receiving HAART.

Navarro JT, Vall-Llovera F, Mate JL, Morgades M, Feliu E, Ribera JM.

Haematologica. 2008 Jan;93(1):149-50. doi: 10.3324/haematol.11767.

42.
43.

Response to highly active antiretroviral therapy as the only therapy in an HIV-infected patient with interfollicular Hodgkin's lymphoma.

Xicoy B, Ribera JM, Romeu J, Mate JL, Millà F, Feliu E.

Leuk Lymphoma. 2007 Oct;48(10):2058-9. No abstract available.

PMID:
17917974
44.

Parkin and synphilin-1 isoform expression changes in Lewy body diseases.

Humbert J, Beyer K, Carrato C, Mate JL, Ferrer I, Ariza A.

Neurobiol Dis. 2007 Jun;26(3):681-7. Epub 2007 Mar 27.

PMID:
17467279
45.

Rarity of JC virus DNA sequences and early proteins in human gliomas and medulloblastomas: the controversial role of JC virus in human neurooncogenesis.

Muñoz-Mármol AM, Mola G, Ruiz-Larroya T, Fernández-Vasalo A, Vela E, Mate JL, Ariza A.

Neuropathol Appl Neurobiol. 2006 Apr;32(2):131-40.

PMID:
16599942
46.

c-Met Mutational Analysis in the Sema and Juxtamembrane Domains in Small-Cell-Lung-Cancer.

de Aguirre I, Salvatierra A, Font A, Mate JL, Perez M, Botia M, Taron M, Rosell R.

Transl Oncogenomics. 2006 Sep 21;1:11-8. Print 2006.

47.

Usefulness of tumor markers CA 125 and CA 15.3 at diagnosis and during follow-up in non-Hodgkin's lymphoma: study of 200 patients.

Batlle M, Ribera JM, Oriol A, Pastor C, Mate JL, Fernández-Avilés F, Flores A, Millá F, Feliu E.

Leuk Lymphoma. 2005 Oct;46(10):1471-6.

PMID:
16194893
48.

Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomas.

Taron M, Ichinose Y, Rosell R, Mok T, Massuti B, Zamora L, Mate JL, Manegold C, Ono M, Queralt C, Jahan T, Sanchez JJ, Sanchez-Ronco M, Hsue V, Jablons D, Sanchez JM, Moran T.

Clin Cancer Res. 2005 Aug 15;11(16):5878-85.

49.

Mutations in the tyrosine kinase domain of the EGFR gene associated with gefitinib response in non-small-cell lung cancer.

Rosell R, Ichinose Y, Taron M, Sarries C, Queralt C, Mendez P, Sanchez JM, Nishiyama K, Moran T, Cirauqui B, Mate JL, Besse B, Reguart N, Perez M, Sanchez JJ.

Lung Cancer. 2005 Oct;50(1):25-33.

PMID:
16011858
50.

Cystathionine beta synthase as a risk factor for Alzheimer disease.

Beyer K, Lao JI, Carrato C, Rodriguez-Vila A, Latorre P, Mataró M, Llopis MA, Mate JL, Ariza A.

Curr Alzheimer Res. 2004 May;1(2):127-33.

PMID:
15975077

Supplemental Content

Support Center